Oman Proposes Strait of Hormuz Plan as U.S., Iran Remain Divided Over Shipping Fees 
Is Netanyahu’s star waning in Washington? His latest meeting with Trump suggests it may be 
China Vows Retaliation Over U.S. Ban on Chinese Robots, Power Inverters 
Ukraine’s drone strikes are having an impact on Russia — but Russian leaders remain committed to war 
California ICE Detention Center Found to Have Inadequate Medical Care, Court Monitor Says 
Iran Fires Ballistic Missiles at U.S. Forces; All Intercepted, CENTCOM Says 
Spain Deploys Troops as Ceuta Faces Major Migrant Surge From Morocco 
Trump Administration to Ban Chinese Robots, Power Inverters Over AI Security Concerns 
Zelenskiy Urges Trump for More Anti-Ballistic Missile Systems to Strengthen Ukraine Defense 
Ukraine Drones Strike Russian Oil Refineries, Wildberries Warehouses as Cross-Border Attacks Escalate 
North Korea Warns U.S. Forces Japan Expansion Raises Korea Conflict Risk 
Trump, Netanyahu Discuss Iran Nuclear Options as Tensions Escalate 
Oman Proposes Strait of Hormuz Plan as U.S. Rejects Iran Shipping Fee Idea 
South Korea Reviews Border Drone Incident After Troops Mistake U.S. Aircraft for Potential Threat 
Taiwan to Test Wartime Weapons Production in Han Kuang Military Drills 
UN Warns of Rising Israeli Settler Violence in West Bank as Palestinian Death Toll Grows 
U.S., Saudi Forces Launch Precision Strikes on Iran-Backed Militants in Iraq 
U.S. President Donald Trump recently sparked renewed discussion around cannabidiol regulation after calling on Congress to modernize existing laws to allow broader access to “full-spectrum” CBD products. In a post shared on Truth Social, Trump emphasized the need for updated legislation that ensures Americans can benefit from the full range of hemp-derived compounds, not just isolated CBD.
Full-spectrum CBD refers to products that contain a variety of naturally occurring cannabinoids, terpenes, and other compounds found in the cannabis plant, including trace amounts of THC within federally legal limits. Advocates argue that these compounds work together in what is known as the “entourage effect,” potentially enhancing the therapeutic benefits of CBD for issues such as anxiety, chronic pain, inflammation, and sleep disorders.
Trump’s statement highlights a growing debate in the U.S. CBD market, where current regulations remain fragmented and often unclear. While the 2018 Farm Bill legalized hemp-derived CBD at the federal level, restrictions and inconsistencies continue to limit consumer access to certain formulations, particularly full-spectrum products. Industry leaders and stakeholders have long pushed for clearer guidelines to support innovation, ensure product safety, and expand market opportunities.
The call for reform also reflects increasing consumer demand for natural wellness solutions. The global CBD market has seen rapid growth, driven by rising awareness of its potential health benefits and shifting public perception of cannabis-related products. However, regulatory uncertainty has slowed progress in areas such as product labeling, quality control, and interstate commerce.
By urging Congress to revisit CBD legislation, Trump has added momentum to ongoing discussions about cannabis policy reform in the United States. Supporters believe that updated laws could strengthen the domestic hemp industry, create jobs, and provide consumers with safer, more effective CBD options. As lawmakers consider potential changes, the future of full-spectrum CBD products in the U.S. remains a closely watched issue for both businesses and consumers alike.
